Advertisement
BMI vs NOVT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMI is a Hold and NOVT is a StrongBuy.
BMI saw its Stochastic Oscillator recovers from the overbought zone
The Stochastic Oscillator for BMI moved out of overbought territory on October 15, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 63 similar instances where the indicator exited the overbought zone. In 40 of the 63 cases the stock moved lower. This puts the odds of a downward move at 63%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
The Aroon Indicator for BMI entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BMI as a result. In 58 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for BMI just turned positive on October 09, 2026. Looking at past instances where BMI's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.
BMI moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 183 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.597) is normal, around the industry mean (1.792). P/E Ratio (30.665) is within average values for comparable stocks, (7.746). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.013) settles around the average of (0.011) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).
The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
NOVT in upward trend: price may jump up because it broke its lower Bollinger Band on October 16, 2026
NOVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 43 cases where NOVT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NOVT's RSI Oscillator exited the oversold zone, 17 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 64 cases where NOVT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
Following a +6.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOVT advanced for three days, in 196 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NOVT as a result. In 72 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for NOVT turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 35 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.
NOVT moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
The Aroon Indicator for NOVT entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. NOVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.197) is normal, around the industry mean (1.792). P/E Ratio (85.950) is within average values for comparable stocks, (7.746). NOVT's Projected Growth (PEG Ratio) (23.270) is slightly higher than the industry average of (5.470). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (5.043) is also within normal values, averaging (32.028).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NOVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
BMI | NOVT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 72 | 41 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 75 Overvalued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 84 | 100 | |
SMR RATING 1..100 | 49 | 83 | |
PRICE GROWTH RATING 1..100 | 58 | 48 | |
P/E GROWTH RATING 1..100 | 74 | 15 | |
SEASONALITY SCORE 1..100 | n/a | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BMI's Valuation (75) in the Electronic Equipment Or Instruments industry is in the same range as NOVT (96). This means that BMI’s stock grew similarly to NOVT’s over the last 12 months.
BMI's Profit vs Risk Rating (84) in the Electronic Equipment Or Instruments industry is in the same range as NOVT (100). This means that BMI’s stock grew similarly to NOVT’s over the last 12 months.
BMI's SMR Rating (49) in the Electronic Equipment Or Instruments industry is somewhat better than the same rating for NOVT (83). This means that BMI’s stock grew somewhat faster than NOVT’s over the last 12 months.
NOVT's Price Growth Rating (48) in the Electronic Equipment Or Instruments industry is in the same range as BMI (58). This means that NOVT’s stock grew similarly to BMI’s over the last 12 months.
NOVT's P/E Growth Rating (15) in the Electronic Equipment Or Instruments industry is somewhat better than the same rating for BMI (74). This means that NOVT’s stock grew somewhat faster than BMI’s over the last 12 months.
| BMI | NOVT | |
|---|---|---|
| RSI ODDS (%) | N/A | 4 days ago 65% |
| Stochastic ODDS (%) | 2 days ago 63% | 2 days ago 64% |
| Momentum ODDS (%) | 2 days ago 61% | 2 days ago 74% |
| MACD ODDS (%) | 2 days ago 81% | 2 days ago 64% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 71% |
| TrendMonth ODDS (%) | 2 days ago 62% | 2 days ago 63% |
| Advances ODDS (%) | 2 days ago 60% | 2 days ago 65% |
| Declines ODDS (%) | 4 days ago 58% | 7 days ago 69% |
| BollingerBands ODDS (%) | N/A | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 58% | 2 days ago 77% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMI’s FA Score shows that 0 FA rating(s) are green while NOVT’s FA Score has 1 green FA rating(s).
- BMI’s FA Score: 0 green, 5 red.
- NOVT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMI’s TA Score shows that 4 TA indicator(s) are bullish while NOVT’s TA Score has 4 bullish TA indicator(s).
- BMI’s TA Score: 4 bullish, 3 bearish.
- NOVT’s TA Score: 4 bullish, 5 bearish.
Price Growth
BMI (@Electronic Equipment/Instruments) experienced а +2.65% price change this week, while NOVT (@Electronic Equipment/Instruments) price change was -0.09% for the same time period.
The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was -3.39%. For the same industry, the average monthly price growth was -13.90%, and the average quarterly price growth was -16.41%.
Reported Earning Dates
BMI is expected to report earnings on Oct 22, 2026.
NOVT is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Electronic Equipment/Instruments (-3.39% weekly)This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IWL | 192.23 | 1.16 | +0.61% |
| iShares Russell Top 200 ETF (IWL) | |||
| DDTY | 20.87 | 0.06 | +0.31% |
| Innovator Equity Dual Directional 10 Buffer ETF - MAY (DDTY) | |||
| GMAR | 45.49 | 0.05 | +0.11% |
| FT Vest U.S. Equity Moderate Buffer ETF - March (GMAR) | |||
| MBBB | 20.35 | N/A | +0.02% |
| VanEck Moody's Analytics BBB Corporate Bond ETF (MBBB) | |||
| BBP | 104.94 | -0.86 | -0.82% |
| Virtus Biotech ETF (BBP) | |||